111 related articles for article (PubMed ID: 12458565)
1. Theratechnologies expands peptide portfolio in endocrinology.
Walczak IM
Diabetes Technol Ther; 2002; 4(5):734. PubMed ID: 12458565
[No Abstract] [Full Text] [Related]
2. [A therapeutic option for type-2 diabetes. The incretion hormone GLP-1].
Göke B; Hoppe B; Konrad A; Schirra J
Pharm Unserer Zeit; 2002; 31(3):294-9. PubMed ID: 12071126
[No Abstract] [Full Text] [Related]
3. A gut response. The next generation of type 2 drugs.
Kordella T
Diabetes Forecast; 2004 Apr; 57(4):39-42. PubMed ID: 15119299
[No Abstract] [Full Text] [Related]
4. [The role of incretins. Type 2 diabetes with new beginnings].
MMW Fortschr Med; 2005 Mar; 147(10):48-9. PubMed ID: 15803785
[No Abstract] [Full Text] [Related]
5. [Novel therapy in type 2 diabetes: to regulate glucose metabolism naturally].
MMW Fortschr Med; 2005 Aug; 147(31-32):54-5. PubMed ID: 16128202
[No Abstract] [Full Text] [Related]
6. Novel "second-generation" approaches for the control of type 2 diabetes.
Rotella DP
J Med Chem; 2004 Aug; 47(17):4111-2. PubMed ID: 15293978
[No Abstract] [Full Text] [Related]
7. Glucagon-like peptide-1: the basis of a new class of treatment for type 2 diabetes.
Knudsen LB
J Med Chem; 2004 Aug; 47(17):4128-34. PubMed ID: 15293981
[No Abstract] [Full Text] [Related]
8. On the treatment of diabetes mellitus with glucagon-like peptide-1.
Holst JJ; Deacon C; Toft-Nielsen MB; Bjerre-Knudsen L
Ann N Y Acad Sci; 1998 Dec; 865():336-43. PubMed ID: 9928027
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes.
Nauck MA
Horm Metab Res; 2004; 36(11-12):852-8. PubMed ID: 15655719
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of diabetes mellitus. New developments and hopes].
Verspohl EJ
Med Monatsschr Pharm; 2005 Jun; 28(6):193-202; quiz 203. PubMed ID: 15960421
[No Abstract] [Full Text] [Related]
11. On combination therapy of diabetes with metformin and dipeptidyl peptidase IV inhibitors.
Hinke SA; McIntosh CH; Hoffmann T; Kühn-Wache K; Wagner L; Bär J; Manhart S; Wermann M; Pederson RA; Demuth HU
Diabetes Care; 2002 Aug; 25(8):1490-1; author reply 1491-2. PubMed ID: 12145269
[No Abstract] [Full Text] [Related]
12. Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans.
Dupre J
Regul Pept; 2005 Jun; 128(2):149-57. PubMed ID: 15780434
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter.
Larsen PJ; Holst JJ
Regul Pept; 2005 Jun; 128(2):97-107. PubMed ID: 15780429
[TBL] [Abstract][Full Text] [Related]
14. Potential therapies mimicking the effects of glucagon-like peptide-1 for the treatment of type 2 diabetes.
Rachman J
Diabet Med; 2004 Jan; 21 Suppl 1():18-20. PubMed ID: 15088933
[No Abstract] [Full Text] [Related]
15. Research advances in the treatment of type 2 diabetes mellitus.
Caro J; Wishner KL
Int J Clin Pract Suppl; 1999 Sep; 107():23-33. PubMed ID: 10692729
[No Abstract] [Full Text] [Related]
16. Improvement of metabolic state in an animal model of nutrition-dependent type 2 diabetes following treatment with S 23521, a new glucagon-like peptide 1 (GLP-1) analogue.
Uçkaya G; Delagrange P; Chavanieu A; Grassy G; Berthault MF; Ktorza A; Cerasi E; Leibowitz G; Kaiser N
J Endocrinol; 2005 Mar; 184(3):505-13. PubMed ID: 15749809
[TBL] [Abstract][Full Text] [Related]
17. [New diabetes therapy in clinical trial: will need adapted insulin supply be available soon? (interview by Dr. Judith Neumaier)].
Allolio B
MMW Fortschr Med; 2004 Feb; 146(9):10. PubMed ID: 15352699
[No Abstract] [Full Text] [Related]
18. The European Association for the Study of Diabetes Annual Meeting, 1998. Treatment of type 2 diabetes and the pathogenesis of complications.
Bloomgarden ZT
Diabetes Care; 1999 Jul; 22(7):1209-15. PubMed ID: 10388992
[No Abstract] [Full Text] [Related]
19. The potential role of glucagon-like peptide 1 in diabetes.
Meier JJ; Nauck MA
Curr Opin Investig Drugs; 2004 Apr; 5(4):402-10. PubMed ID: 15134281
[TBL] [Abstract][Full Text] [Related]
20. [Analogs of glucagon-like peptide-1 (GLP-1): an old concept as a new treatment of patients with diabetes mellitus type 2].
Diamant M; Bunck MC; Heine RJ
Ned Tijdschr Geneeskd; 2004 Sep; 148(39):1912-7. PubMed ID: 15495988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
